ISLAMABAD: The Ministry of National Health Services and Regulations has announced that the Central Drugs Laboratory (CDL), Karachi, of the Drug Regulatory Authority of Pakistan (DRAP), has been prequalified by the World Health Organisation (WHO), confirming that DRAP’s testing services meet stringent international standards and ensuring that medicines evaluated at the facility are safe, effective, and of high quality.
Federal Minister for National Services and Regulation, Mustafa Kamal, on Wednesday appreciated the achievement, congratulating the DRAP for attaining the WHO’s prequalification, saying that the move will elevate Pakistan’s pharmaceutical testing capabilities to the highest international standards.
The minister emphasised that this achievement is a cornerstone of the government’s broader health reforms. “The WHO Prequalification of CDL Karachi is a historic moment for the people of Pakistan,” stated Mustafa Kamal. “Our government is committed to a fundamental shift from a ‘sick-care’ system to a true ‘healthcare’ system that prioritises prevention and quality. Ensuring that every medicine tested in our national labs meets global standards is the first line of defense in protecting the lives of our citizens.”
The Minister further noted that this milestone is critical for the national economy and the “Made in Pakistan” brand. By achieving this international validation, we are not only safeguarding public health but also empowering our pharmaceutical industry to compete globally.
This will foster immense trust among healthcare providers and patients alike, ensuring that no matter where you are in Pakistan, the medicine you receive is a product of world-class integrity.”
Copyright Business Recorder, 2026
Comments